Europe CEO
Date: Location: Cost:
November 14, 2017 Four Seasons Hotel London at Park Lane
Hamilton Place, Park Lane
London, England W1J 7DR
44 (20) 7499-0888
Location >

Starting at $1950


Dress Code:
Business Attire


Europe CEO - November 14, Four Seasons London

Co-hosts and Speakers include: Adam Bruce, CEO & Founder, Tikomed; Luc Dochez, CEO, Tusk Therapeutics; Marc de Garidel, Chairman, IPSEN; Don DeBethizy, Chairman, Albumedix; John Haurum, CEO, F-Star Biotechnology; Adi Hoess, CEO, Affimed; Ed Kaye, former CEO, Sarepta; Jonathan LewisCEO, Samus Therapeutics; Ivana Magovcevic-LiebischEVP, Axcella Health; Elias Papatheodorou, CEO, Genkyotex; Joe WileyCEO, Amryt Pharma;Thomas Lonngren, former Executive Director, European Medicines Agency 

Time Agenda
7:00-8:00 am

Registration and Networking Breakfast

8:00-8:30 am

Welcome and Opening Remarks
Luc Dochez
, CEO, Tusk Therapeutics

8:30-9:00 am

Alternate Sources of Funding
Steve Eror
, President & CEO, Prolung; David Rossow, Head of International Strategic Investments, Gates Foundation

9:00-10:00 am

Global Perspectives on Funding: The VC Perspective

10:00-10:20 am

Moderated Keynote

10:20-10:50 am

Networking Break

10:50-11:20 am

Regulatory Hurdles: Access Across Borders
Thomas Lonngren
, Strategy Advisor, NDA Group

11:20-11:50 am

Gaining Investment Overseas
Adi Hoess
, CEO, Affimed Therapeutics AG; Joe Wiley, CEO, Amyrt Pharma

11:50-12:20 pm

Public and Private Markets: Challenges and Opportunities across Borders
Don DeBithizy
, Chairman, Albumedix; Marc de Garidel, Chairman, Ipsen; Annette Grimaldi, Managing Director, BMO Capital Markets; Elias Papatheodorou, CEO, Genkyotex

12:20-1:20 pm

Networking Lunch

1:20-1:50 pm

The Impact of ACA Reform and Brexit on Global Markets
John Haurum
, CEO, F-Star; Jonathan Lewis, CEO, Samus Therapeutics

1:50-2:20 pm

Biotech Partnering: Strategies for Success
Donna Armentano
, Executive Director, Pfizer; Sophie Kornowski-Bonnet, Head, Roche Partnering; Philippe Lopes-Fernandes, SVP, EMD Serono; Ivana Magovcevic-Liebisch, EVP, Chief Strategy & Corp. Dev. Officer, Axcella Health; Erik van den Berg, CEO, AM-Pharma

2:20-2:50 pm

Academia & Biotech Collaborations: Lessons Learned from Global Markets
Adam Bruce
, CEO, Tikomed; George Goldsmith, Chairman, Founder, Compass Pathways; Keith Marmer, Executive Director, Technology & Venture Commercialization, University of Utah

2:50-3:20 pm

Networking Break

3:20-3:50 pm

Fireside Chat
Eugenio Aringhieri,
CEO, Dompa Farmaceutici
Moderator: Luc Dochez, CEO, Tusk Therapeutics

3:50-4:20 pm

Therapeutic Market Focus: Immuno-Oncology
Arman Mangasarian
, CEO, NOXXON Pharma

4:20-4:50 pm

Leveraging Emerging Markets
Moderator: Florian Kemmerich, Managing Partner, Bamboo Capital Markets

4:50-5:20 pm

Navigating Market Access
Ed Kaye
, President, CEO & CMO, Sarepta Therapeutics

5:20-6:00 pm

Cocktail Reception

Supporting Sponsors: (see all sponsors)